The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus.
作者信息
Yoo Jeong-Ju, Kim Sang Gyune
机构信息
Department of Internal Medicine, Soonchunhyang University School of Medicine, Bucheon, Korea.
出版信息
Clin Mol Hepatol. 2023 Jan;29(1):102-104. doi: 10.3350/cmh.2022.0353. Epub 2022 Nov 10.
Abstract
摘要
相似文献
1
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus.
Clin Mol Hepatol. 2023 Jan;29(1):102-104. doi: 10.3350/cmh.2022.0353. Epub 2022 Nov 10.
2
Baveno VII - Renewing consensus in portal hypertension.
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
3
Evolving portal hypertension through Baveno VII recommendations.
Ann Hepatol. 2024 Jan-Feb;29(1):101180. doi: 10.1016/j.aohep.2023.101180. Epub 2023 Nov 19.
4
Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII.
Liver Int. 2023 Sep;43(9):1966-1974. doi: 10.1111/liv.15632. Epub 2023 Jun 8.
5
Non-invasive diagnosis of esophageal varices after Baveno VI.
Turk J Gastroenterol. 2017 May;28(3):159-165. doi: 10.5152/tjg.2017.16744.
6
[Baveno VII - Renewing consensus in portal hypertension: personalized care for portal hypertension].
Zhonghua Gan Zang Bing Za Zhi. 2022 Jan 20;30(1):21-29. doi: 10.3760/cma.j.cn501113-20220109-00010.
7
Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII - an update.
Dig Liver Dis. 2023 Mar;55(3):326-335. doi: 10.1016/j.dld.2022.10.009. Epub 2022 Nov 8.
8
Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis.
Esophagus. 2020 Jan;17(1):19-24. doi: 10.1007/s10388-019-00699-4. Epub 2019 Oct 16.
9
Non-invasive tests-based risk stratification: Baveno VII and beyond.
Clin Mol Hepatol. 2023 Jan;29(1):105-109. doi: 10.3350/cmh.2022.0361. Epub 2022 Nov 23.
10
[Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
Zhonghua Gan Zang Bing Za Zhi. 2022 Oct 20;30(10):1092-1099. doi: 10.3760/cma.j.cn501113-20210126-00044.
引用本文的文献
1
Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study.
Clin Mol Hepatol. 2025 Jul;31(3):881-898. doi: 10.3350/cmh.2024.0898. Epub 2025 Feb 5.
2
Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase".
Clin Mol Hepatol. 2023 Apr;29(2):513-515. doi: 10.3350/cmh.2023.0044. Epub 2023 Feb 15.
本文引用的文献
1
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.
Clin Mol Hepatol. 2023 Jan;29(1):135-145. doi: 10.3350/cmh.2022.0181. Epub 2022 Sep 5.
2
Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
J Hepatol. 2022 Dec;77(6):1564-1572. doi: 10.1016/j.jhep.2022.07.037. Epub 2022 Aug 28.
3
Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement.
Endoscopy. 2022 Aug;54(8):797-826. doi: 10.1055/a-1859-3726. Epub 2022 Jul 8.
4
Baveno VII - Renewing consensus in portal hypertension.
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
5
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis.
Hepatol Commun. 2022 May;6(5):950-964. doi: 10.1002/hep4.1855. Epub 2021 Dec 14.
6
A need for patient-centered care in managing patients with liver cirrhosis.
Clin Mol Hepatol. 2021 Apr;27(2):270-272. doi: 10.3350/cmh.2021.0001. Epub 2021 Jan 27.
7
The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.
Clin Mol Hepatol. 2021 Jan;27(1):197-206. doi: 10.3350/cmh.2020.0171. Epub 2020 Dec 3.
8
The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
Clin Mol Hepatol. 2021 Jan;27(1):91-93. doi: 10.3350/cmh.2020.0311. Epub 2020 Dec 3.
9
Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
Eur Radiol. 2021 Apr;31(4):2392-2404. doi: 10.1007/s00330-020-07223-8. Epub 2020 Sep 24.
10
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.
Clin Mol Hepatol. 2020 Apr;26(2):83-127. doi: 10.3350/cmh.2019.0010n. Epub 2020 Jan 10.
Zotero 插件